Nabis Holdings Inc (CSE:NAB) (OTCMKTS:NABIF) is launching a new brand of cannabidiol product lines for medical, lifestyle and wellness consumers, it announced Thursday.
The Be In Synergy (BIS) line will include a range of CBD-related exclusive brands, such as edibles, vapes, patches, cosmetics and skincare products.
The cannabis company told shareholders that BIS has exclusive US rights for a state-of-the-art oral spray for various cannabis-based products like oils and liquids. The system has an air and watertight design to prolong its shelf life.
Vancouver-based Nabis said that a line of sublingual strips developed in conjunction with Israeli cannabis company Cannova Medical will launch under the BIS brand label. The strips allow for rapid cannabis absorption which bypasses the liver metabolism.
“Our creation of the BIS brand of CBD products reflect our commitment to excellence and consumer satisfaction,” said Nabis’s CEO Shay Shnet.
“As we continue to expand the BIS brand, we are excited to present an elegant product line that we believe will fill a demand that has remained unmet in the cannabis and CBD industry until now.”
BIS products will be available in the US by late 2019 throughout Nabis dispensaries and online at BeInSynergy.com.
The company also told investors on Thursday that it is not proceeding with its acquisitions of Organica Patient Group and RDF Management, as well as its 70% stake in Hivemind Refinery.
Earlier this week, Nabis closed on the acquisition of a cultivation, production and fulfilment facility in Camp Verde, Arizona, its second deal in the state.
Contact Angela at [email protected]
Follow her on Twitter @AHarmantas